By Tom Lydon : The biotechnology sector has positive long-term implications and the indecision that loomed over the industry has subsided, according to S&P Capital. Exchange traded funds that track this sector are a sound choice for risk mitigation while gaining exposure to growth going forward. ...
best performing industries this year has been biotechnology. The S&P biotechnology ETF ( XBI ) and the Nasdaq Biotech ETF ( IBB ) have returned 27% and 18% year-to-date, respectively. Those returns are nicely ahead of the 14% return clocked by
SYDNEY, April 30 (Reuters) - Islamic Bank of Britain ( IBB ) narrowed its losses in 2012, Britain's only sharia-compliant retail lender said, a week after it raised 10 million pounds ($15.5 million) from majority shareholder Qatar International Islamic Bank.
largest ETF in the biotech sector is the iShares Biotech ETF ( IBB ). The fund currently has $2.88 billion in total assets spread ..... companies with an expense ratio of 0.48%. The top three holdings in IBB include: Regeneron Complete Story »
yield is about 10.71% and pays quaterly. http://www. ibb .ubs.com/mc/etracs_US/mlp/alerian-long.shtml ..... yield is about 18.71% and pays quaterly. http://www. ibb .ubs.com/mc/etracs_US/bdc/wellsfargo-long.shtml
Vectors Biotech ETF ( BBH ) was leading the way with a year-to-date gain of over 21 percent. The iShares Nasdaq Biotechnology Index Fund ( IBB ), the largest biotech ETF by assets, has not been a slouch with a gain of 20.5 percent while
highs across the board: Health Care SPDR ( XLV +1% ), Vanguard Health Care ETF ( VHT +0.9% ), iShares Dow Jones US Healthcare ( IYH +0.9% ),. Biotech ETF iShares NASDAQ Biotechnology Index ( IBB +1.3% ). Post your comment!
By Brian L. Wilson : The fierce and unending battle between Dendreon (NASDAQ: DNDN ) bulls and bears has entered new territory: TV advertising. In a rather unconventional and unusual move, Dendreon management has been purchasing airtime for its Provenge commercial (which can be viewed here ). From
Q2 2013- At All Time Highs The BTK and ETFs such as the IBB ( IBB ) and XBI ( XBI ) hit all time highs on April 2. Of course ..... points ago on the NASDAQ . Since 2012, the biotech ETF IBB has decoupled from NASDAQ and has outperformed it by 80
By John Dowdee : One of the central tenets of asset allocation is to select a diversified portfolio. The idea is intuitive; you do not keep all your eggs in one basket. Everyone talks about being diversified but there is little discussion on how you measure the degree of diversification. ...